Federal Register / Vol. 87, No. 18 / Thursday, January 27, 2022 / Notices 4229 

discriminatory or preferential. PJM 

Interconnection, L.L.C., 178 FERC 

¶ 61,021 (2022). 

The refund effective date in Docket 

No. EL22–22–000, established pursuant 

to section 206(b) of the FPA, will be the 

date of publication of this notice in the 

Federal Register. 

Any interested person desiring to be 

heard in Docket No. EL22–22–000 must 

file a notice of intervention or motion to 

intervene, as appropriate, with the 

Federal Energy Regulatory Commission, 

in accordance with Rule 214 of the 

Commission’s Rules of Practice and 

Procedure, 18 CFR 385.214 (2021), 

within 21 days of the date of issuance 

of the order. 

In addition to publishing the full text 

of this document in the Federal 

Register, the Commission provides all 

interested persons an opportunity to 

view and/or print the contents of this 

document via the internet through the 

Commission’s Home Page (http://

www.ferc.gov) using the ‘‘eLibrary’’ link. 

Enter the docket number excluding the 

last three digits in the docket number 

field to access the document. At this 

time, the Commission has suspended 

access to the Commission’s Public 

Reference Room, due to the 

proclamation declaring a National 

Emergency concerning the Novel 

Coronavirus Disease (COVID–19), issued 

by the President on March 13, 2020. For 

assistance, contact FERC at 

FERCOnlineSupport@ferc.gov or call 

toll-free, (886) 208–3676 or TYY, (202) 

502–8659. 

The Commission strongly encourages 

electronic filings of comments, protests 

and interventions in lieu of paper using 

the ‘‘eFile’’ link at http://www.ferc.gov. 

In lieu of electronic filing, you may 

submit a paper copy. Submissions sent 

via the U.S. Postal Service must be 

addressed to: Kimberly D. Bose, 

Secretary, Federal Energy Regulatory 

Commission, 888 First Street NE, Room 

1A, Washington, DC 20426. 

Submissions sent via any other carrier 

must be addressed to: Kimberly D. Bose, 

Secretary, Federal Energy Regulatory 

Commission, 12225 Wilkins Avenue, 

Rockville, Maryland 20852. 

Dated: January 21, 2022. 

Debbie-Anne A. Reese, 

Deputy Secretary. 

[FR Doc. 2022–01636 Filed 1–26–22; 8:45 am] 

BILLING CODE 6717–01–P 

ENVIRONMENTAL PROTECTION 

AGENCY 

[EPA–HQ–OPPT–2021–0146; FRL–8682–09– 

OCSPP] 

Certain New Chemicals or Significant 

New Uses; Statements of Findings for 

December 2021 

AGENCY: Environmental Protection 

Agency (EPA). 

ACTION: Notice. 

SUMMARY: The Toxic Substances Control 

Act (TSCA) requires the Environmental 

Protection Agency (EPA) to publish in 

the Federal Register a statement of its 

findings after its review of certain TSCA 

notices when EPA makes a finding that 

a new chemical substance or significant 

new use is not likely to present an 

unreasonable risk of injury to health or 

the environment. Such statements apply 

to premanufacture notices (PMNs), 

microbial commercial activity notices 

(MCANs), and significant new use 

notices (SNUNs) submitted to EPA 

under TSCA. This document presents 

statements of findings made by EPA on 

such submissions during the period 

from December 1, 2021 to December 31, 

2021. 

FOR FURTHER INFORMATION CONTACT: For 

technical information contact: Rebecca 

Edelstein, Chemical Control Division 

(7405M), Office of Pollution Prevention 

and Toxics, Environmental Protection 

Agency, 1200 Pennsylvania Ave. NW, 

Washington, DC 20460–0001; telephone 

number: 202–564–1667 email address: 

Edelstein.rebecca@epa.gov. 

For general information contact: The 

TSCA-Hotline, ABVI-Goodwill, 422 

South Clinton Ave., Rochester, NY 

14620; telephone number: (202) 554– 

1404; email address: TSCA-Hotline@

epa.gov. 

SUPPLEMENTARY INFORMATION: 

I. General Information 

A. Does this action apply to me? 

This action is directed to the public 

in general. As such, the Agency has not 

attempted to describe the specific 

entities that this action may apply to. 

Although others may be affected, this 

action applies directly to the submitters 

of the PMNs addressed in this action. 

B. How can I get copies of this document 

and other related information? 

The docket for this action, identified 

by docket identification (ID) number 

EPA–HQ–OPPT–2021–0146, is available 

online at http://www.regulations.gov or 

at the Office of Pollution Prevention and 

Toxics Docket (OPPT Docket), 

Environmental Protection Agency 

Docket Center (EPA/DC), West William 

Jefferson Clinton Bldg., Rm. 3334, 1301 

Constitution Ave. NW, Washington, DC. 

The Public Reading Room is open from 

8:30 a.m. to 4:30 p.m., Monday through 

Friday, excluding legal holidays. The 

telephone number for the Public 

Reading Room is (202) 566–1744, and 

the telephone number for the OPPT 

Docket is (202) 566–0280. 

Due to the public health concerns 

related to COVID–19, the EPA Docket 

Center (EPA/DC) and Reading Room is 

opened to visitors by appointment only. 

For the latest status information on 

EPA/DC services and docket access, 

visit https://www.epa.gov/dockets. 

II. What action is the Agency taking? 

This document lists the statements of 

findings made by EPA after review of 

notices submitted under TSCA section 

5(a) that certain new chemical 

substances or significant new uses are 

not likely to present an unreasonable 

risk of injury to health or the 

environment. This document presents 

statements of findings made by EPA 

during the period from December 1, 

2021 to December 31, 2021. 

III. What is the Agency’s authority for 

taking this action? 

TSCA section 5(a)(3) requires EPA to 

review a TSCA section 5(a) notice and 

make one of the following specific 

findings: 

Æ The chemical substance or 

significant new use presents an 

unreasonable risk of injury to health or 

the environment; 

Æ The information available to EPA is 

insufficient to permit a reasoned 

evaluation of the health and 

environmental effects of the chemical 

substance or significant new use; 

Æ The information available to EPA is 

insufficient to permit a reasoned 

evaluation of the health and 

environmental effects and the chemical 

substance or significant new use may 

present an unreasonable risk of injury to 

health or the environment; 

Æ The chemical substance is or will 

be produced in substantial quantities, 

and such substance either enters or may 

reasonably be anticipated to enter the 

environment in substantial quantities or 

there is or may be significant or 

substantial human exposure to the 

substance; or 

Æ The chemical substance or 

significant new use is not likely to 

present an unreasonable risk of injury to 

health or the environment. 

Unreasonable risk findings must be 

made without consideration of costs or 

other non-risk factors, including an 

unreasonable risk to a potentially 


lotter on DSK11XQN23PROD with NOTICES1
4230 Federal Register / Vol. 87, No. 18 / Thursday, January 27, 2022 / Notices 

exposed or susceptible subpopulation 

identified as relevant under the 

conditions of use. The term ‘‘conditions 

of use’’ is defined in TSCA section 3 to 

mean ‘‘the circumstances, as determined 

by the Administrator, under which a 

chemical substance is intended, known, 

or reasonably foreseen to be 

manufactured, processed, distributed in 

commerce, used, or disposed of.’’ EPA is required under TSCA section 

5(g) to publish in the Federal Register 

a statement of its findings after its 

review of a TSCA section 5(a) notice 

when EPA makes a finding that a new 

chemical substance or significant new 

use is not likely to present an 

unreasonable risk of injury to health or 

the environment. Such statements apply 

to PMNs, MCANs, and SNUNs 

submitted to EPA under TSCA section 

5. 

Anyone who plans to manufacture 

(which includes import) a new chemical 

substance for a non-exempt commercial 

purpose and any manufacturer or 

processor wishing to engage in a use of 

a chemical substance designated by EPA 

as a significant new use must submit a 

notice to EPA at least 90 days before 

commencing manufacture of the new 

chemical substance or before engaging 

in the significant new use. The submitter of a notice to EPA for 

which EPA has made a finding of ‘‘not 

likely to present an unreasonable risk of 

injury to health or the environment’’ 

may commence manufacture of the 

chemical substance or manufacture or 

processing for the significant new use 

notwithstanding any remaining portion 

of the applicable review period. 

IV. What are the statements of 

administrator Findings under TSCA 

section 5(a)(3)(C)? 

In this unit, EPA provides the 

following information (to the extent that 

such information is not claimed as 

Confidential Business Information 

(CBI)) on the PMNs, MCANs and 

SNUNs for which, during this period, 

EPA has made findings under TSCA 

section 5(a)(3)(C) that the new chemical 

substances or significant new uses are 

not likely to present an unreasonable 

risk of injury to health or the 

environment: 

Æ EPA case number assigned to the 

TSCA section 5(a) notice. 

Æ Chemical identity (generic name if 

the specific name is claimed as CBI). 

Æ Website link to EPA’s decision 

document describing the basis of the 

‘‘not likely to present an unreasonable 

risk’’ finding made by EPA under TSCA 

section 5(a)(3)(C). 

EPA case No. Chemical identity Website link 

P–18–0348 ......... Ethanol, 2,2’-[1,4-phenylenebis(oxy)]bis-, polymer with 1,6- 

diisocyanatohexane and .alpha.-hydro-.omega.-hydroxypoly(oxy1,4-butanediyl) (specific).

https://www.epa.gov/system/files/documents/2022-01/ 

p-18-0348_determination_non-cbi_final.pdf. 

P–20–0018; P– 

20–0019; P– 

20–0020; P– 

20–0021.

P–20–0018, P–20–0019, P–20–0020: Fatty acid dimers, polymers 

with glycerol and triglycerides (generic) P–20–0021: Fatty acid 

dimers, polymers with glycerol and fatty acids (generic).

https://www.epa.gov/system/files/documents/2022-01/ 

p-20-0018-0021_determination_non-cbi_final.pdf. 

P–21–0120 ......... 2-Alkenoic acid, 2-alkyl-, 2-hydroxyalkyl ester, homopolymer, ester 

with N-[3-[(carboxyamino)alkyl]-3,5,5- trialkylcycloalkyl]carbamic 

acid mono [2-(2-alkoxyethoxy)alkyl] ester, N-[3- 

[(carboxyamino)alkyl]-3,5,5- trialkylcycloalkyl] carbamic acid mono 

[2-(dialkylamino) alkyl] ester and 2-oxepanone polymer with 

tetrahydro- 2H-pyran-2-one 2-alkylhexyl ester N-[3- 

(carboxyamino)alkyl phenyl] carbamate, 1,1-dialkylpropyl 2- 

alkylhexaneperoxoate—initiated (generic).

https://www.epa.gov/system/files/documents/2022-01/ 

p-21-0120_determination_non-cbi_final.pdf. 

P–21–0135 ......... Alkenoic acid, allyl-, (dialkylamino)alkyl ester, polymer with dialkyl-alkylene-alkanediyl)bis[carbomoncycle], alkylalkyl alkyl-alkenoate 

and alkanediol mono(2-alkyl-alkenoate), diazenediyl)bis[2- 

alkylalkanenitrile]-initiated, (generic).

https://www.epa.gov/system/files/documents/2022-01/ 

p-21-0135_determination_non-cbi_final.pdf. 

P–21–0186; P– 

21–0187.

glycerin, alkoxylated alkyl acid esters (generic) ................................... https://www.epa.gov/system/files/documents/2022-01/ 

p-21-0186-0187_determination_non-cbi_final.pdf. 

Authority: 15 U.S.C. 2601 et seq. 

Dated: January 24, 2022. 

Madison Le, 

Director, New Chemicals Division, Office of 

Pollution Prevention and Toxics. 

[FR Doc. 2022–01647 Filed 1–26–22; 8:45 am] 

BILLING CODE 6560–50–P 

ENVIRONMENTAL PROTECTION 

AGENCY 

[EPA–HQ–OAR–2020–0660; FRL–9507–01– 

OMS] 

Information Collection Request 

Submitted to OMB for Review and 

Approval; Comment Request; NSPS 

for Nonmetallic Mineral Processing 

(Renewal) 

AGENCY: Environmental Protection 

Agency (EPA). 

ACTION: Notice. 

SUMMARY: The Environmental Protection 

Agency (EPA) has submitted an 

information collection request (ICR), 

NSPS for Nonmetallic Mineral 

Processing (EPA ICR Number 1084.15, 

OMB Control Number 2060–0050), to 

the Office of Management and Budget 

(OMB) for review and approval in 

accordance with the Paperwork 

Reduction Act. This is a proposed 

extension of the ICR, which is currentlyapproved through March 31, 2022. 

Public comments were previously 

requested, via the Federal Register, on 

February 8, 2021 during a 60-day 

comment period. This notice allows for 

an additional 30 days for public 

comments. A fuller description of the 

ICR is given below, including its 

estimated burden and cost to the public. 

An agency may neither conduct nor 

sponsor, and a person is not required to 

respond to, a collection of information 

unless it displays a currently valid OMB 

control number. 

DATES: Additional comments may be 

submitted on or before February 28, 

2022. 


lotter on DSK11XQN23PROD with NOTICES1